BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Dr. Rana McKay
And so I think making sure that that's evaluated. You know, some of these therapies can cause high blood pressure, so monitoring against that. But I think with regards to testing, for me, it's basically a hemoglobin A1c, glucose level, you know, lipid panel. You know, there's been some recent enthusiasm around coronary calcium scores with regards to CV risk.
0
💬
0
Comments
Log in to comment.
There are no comments yet.